 ,Screening, , , , ,Treatment, ,period, , , ,End of treatment/ early termination³,Follow- up4,Primary endpoint visit at,"Unscheduled visit, if applicable6",References (protocol section)
Visit,1,2,3²,4,5,6,7,8,9,10,11,12,13,"Week 16, if", , 
Week,-4 to -1, ,0,1,2,4,6,8,10,12,14,16,18,applicable5, , 
Day,-28 to -7,1,4,8,15,29,43,57,71,85,99,113,127, , , 
Visit window (days¹,-,-,1,3,3,3,3,3,3,3,3,3,3, , , 
Trial population and eligibility, , , , , , , , , , , , , , , , 
Informed consent7,SELECTED X,NOT_SELECTED,NOT_SELECTED, , , , , , , , , , , , ,Appendix 3B
Subject eligibility,SELECTED X,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , , , , , , , ,"8.1,8.2,8.3"
Trial products and randomisation, , , , , , , , , , , , , , , , 
Randomisation,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , , , , , , , ,9.3
Dispense IMP,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,SELECTED X,SELECTED,X,X,X, ,SELECTED X, , , ,(X),9.2
Instruction on IMP application,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , ,NOT_SELECTED,NOT_SELECTED, , , , ,9.2
Application of IMP,NOT_SELECTED, , , , , ,twice,daily, , , , ,NOT_SELECTED,NOT_SELECTED, ,9.2
Treatment compliance,NOT_SELECTED,NOT_SELECTED,X,X,X,X,X, ,X, ,X,X,NOT_SELECTED, , ,"9.8.3,9.8.4"
Return of IMP and accountability8,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,X, , , , ,SELECTED,SELECTED,X,NOT_SELECTED, , ,"9.8.3, 10.3, 10.4"
"Concomitant medication, concurrent procedures9",SELECTED X,SELECTED X,SELECTED X,X,X,X,X,X,X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,SELECTED X,(X),"9.4,9.5,9.6, 9.7"
Demographics,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , ,NOT_SELECTED,NOT_SELECTED,11.2.1
Fitzpatrick skin type,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , ,11.2.2
Medical history10,SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , ,11.2.3
Classification of chronic hand eczema,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , ,11.2.4
Height and weight,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, ,NOT_SELECTED,NOT_SELECTED, ,11.2.5
Determination of the treatment areas,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , ,NOT_SELECTED, , ,NOT_SELECTED, ,11.2.6
eDiary hand out / training,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , , , , , , , ,NOT_SELECTED, ,7.1
Subject assessment of efficacy,#NAME?, , , , , , , , , , , , , , , 
eDiary completion: HESD11, , , , , , - during,daily, , , , , ,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.7.1.1
Subject assessment of efficacy,and,health-related, ,quality,of life,, ,trial,visits, , , , , , , 
HEIS,SELECTED X,SELECTED X,NOT_SELECTED,SELECTED X,X,X,X,X,X,X,X,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.7.1.2
PaGA,SELECTED X,SELECTED,NOT_SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED X,NOT_SELECTED,SELECTED X,NOT_SELECTED,11.7.1.3
PGI-C,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.7.1.4
DLQI,SELECTED X,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.7.1.5
EQ-5D-5L,SELECTED X,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.7.1.6
QOLHEQ,SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED, ,11.7.1.7
WLQ12,SELECTED X,SELECTED X,NOT_SELECTED,NOT_SELECTED, ,X, ,X, , , ,X, ,NOT_SELECTED, ,11.7.1.8
Investigator assessments of,efficacy, , , , , , , , , , , , , , , 
IGA,SELECTED X,SELECTED X,NOT_SELECTED,SELECTED X,X,X,X,X,X,X,X,SELECTED X,NOT_SELECTED,SELECTED X,NOT_SELECTED,11.3.1
HECSI,SELECTED X,SELECTED X,NOT_SELECTED,SELECTED X,SELECTED X, ,X,X,X,SELECTED,SELECTED X,SELECTED X,NOT_SELECTED,SELECTED X,NOT_SELECTED,11.3.2
Investigator assessments of,safety, , , , , , , , , , , , , , , 
Vital signs,SELECTED X,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,(X),11.4.1
Physical examination,SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,(X),11.4.2
ECG,SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,SELECTED (X),11.4.3
"Chemistry, haematology13",SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,SELECTED (X),11.4.4
"Serology, total IgE, tuberculosis test14",SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, ,11.4.4
Serum pregnancy test15,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,(X),11.4.4
Urine pregnancy test15,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,SELECTED (X),11.4.4
Urinalysis - dipstick,SELECTED X,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,SELECTED (X),11.4.4
AEs/SAEs,SELECTED X,SELECTED,SELECTED X16,SELECTED X,SELECTED X,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED X,SELECTED X,SELECTED X,SELECTED X,13
Subject assessment of local tolerability,NOT_SELECTED,NOT_SELECTED,SELECTED,SELECTED X,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,X,NOT_SELECTED,NOT_SELECTED,SELECTED X,11.4.5
PK blood sample,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X17,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, ,11.5.1
Skin swab/skin microbiome,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED, , ,11.6.2
Blood sample for filaggrin mutation status,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, , ,11.6.4
"Skin barrier function (selected sites18, 19",NOT_SELECTED,SELECTED X19,NOT_SELECTED,NOT_SELECTED,SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED, ,11.6.5
Skin biopsy and photography (optional) 19,NOT_SELECTED,SELECTED X19,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,X20,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,11.6.3
Check skin biopsy wound healing/suture removal,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,11.6.3
New chronic hand eczema lesions,NOT_SELECTED,NOT_SELECTED,SELECTED,SELECTED,SELECTED,SELECTED X,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED,SELECTED X,NOT_SELECTED,SELECTED X,SELECTED X,9.2
Return of eDiary,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED, 
End of trial form21, ,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,NOT_SELECTED,SELECTED X,SELECTED X,SELECTED X,NOT_SELECTED,"10.3, 11.9"
